Health-related content. Aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before making decisions. .

ECG Buddy

ECG Buddy

By ARPI

ECG Buddy is an AI-powered medical device app for healthcare professionals that analyzes ECG imagery for arrhythmia and critical biomarkers on iOS and Android.

The App DNA

What makes this app unique?

Users hire the app to accelerate emergency diagnostic decisions by automating the interpretation of ECG scans, reducing the time required for clinical risk assessment.

For Healthcare professionals, including physicians, nurses, and emergency medical technicians, working in hospital or emergency settings.

What does it look like?

Key features

11 Digital Biomarkersedge

Automated numerical and graphical risk assessment for conditions including LVEF, Shock, and STEMI from ECG images

Consult Transmissionedge

Seamlessly transmits analysis results to medical teams during patient transport

How much does it cost?

freemiumFree: 3 analyses/day, 30/monthPaid: $19/month or $190/year for 20 analyses/day, 200/month

The credit-based consumption gate limits free usage while monetizing high-frequency clinical workflows at $19/month.

Velocity

Active developmentnew contentUX improvementsperformanceShow more...

ECG Buddy maintains an active development cadence, shipping updates approximately every 2-3 weeks. The latest release focuses on core functionality improvements, specifically upgrading the AI detection model and optimizing camera performance. Development appears stable, with consistent attention to both Android and iOS platforms. The team is actively iterating on feature performance rather than relying solely on maintenance patches.

See all version history

Who built it?

ARPI

2 apps tracked · Medical

ECG Buddy | ECG Analysis AIECG Buddy | ECG Analysis AI
Explore the full publisher profile

User Sentiment

What do users think recently?

Review voice lately leans frustrated. Users appreciate the app provides high measurement accuracy compared to other health monitoring tools available on mobile.

How are ratings & reviews evolving?

App Store
5.00 · 1
Google Play
0.00 · 0

What users say, by theme

What Users Love
  • The app provides high measurement accuracy compared to other health monitoring tools available on mobile
What Frustrates Users
  • Users report the app fails to progress past the occupation selection screen during the initial setup
+ 2 more themes

4 of 4 recent reviews analyzed · limited sample

Read the full review analysis

Unlock 2 more frustration themes, each backed by review evidence.

Access the full report for free

Competition

Competitive landscape for ECG Buddy

How's the Medical market?

ECG Buddy occupies a niche medical diagnostic space, relying on 17 peer-reviewed papers to differentiate from consumer health trackers. The current geographic gating limits its market reach to pre-approved hospital systems.

Read the market outlook

The rivals identified

Unlock the deeper market read.

Access the full report for free

The Analyst's Read

Key takeaways for ECG Buddy

Where is it heading?

The medical diagnostic market is consolidating around apps that integrate directly with hospital workflows, leaving standalone scan tools like ECG Buddy exposed to displacement. The app's reliance on regional regulatory approval creates a binary growth path: success depends on rapid international expansion, or the app risks being relegated to a regional utility.

  • Onboarding failures at the occupation selection screen block new professional users, which compounds the churn risk for the current user base.
  • The latest release introduces an improved AI model for ECG detection, demonstrating active feature investment rather than maintenance-mode stagnation.

The SWOT

Core Strengths
  • 17 peer-reviewed papers validate clinical utility
  • 11 digital biomarkers provide differentiated diagnostic support
  • Consult transmission feature enables hospital-wide workflow integration
Critical Frictions 3 weaknesses inside
Growth Levers
  • Expand regulatory approval to new regions to unlock global hospital partnerships
  • Integrate with electronic health record systems to improve clinical adoption
Market Threats 2 threats identified

Next best moves

1 Invest · 1 Pivot

Rebuild occupation selection screen because it is the top-reported onboarding blocker → increase new-user conversion

+ 1 more prioritized move

The counter-intuitive read

The app's geographic restriction is not a failure…

Read the full take

Since the last report: The report shows a pivot toward clinical workflow integration and regulatory-driven market positioning, despite ongoing technical blockers in the onboarding funnel.

Bottom line

ECG Buddy delivers high-accuracy clinical insights, but critical onboarding bugs and geographic gating prevent it from scaling beyond its current hospital base, so the PM must prioritize fixing the occupation-selection flow to stabilize the new-user funnel.

Unlock 3 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.

Access the full report for free

Sources

  1. [1] Play Store reviews, source
  2. [2] Developer website, source

Report last updated

Disclosure: Independent intel to help mobile builders succeed.

AI-powered analysis with automated quality gates, built from publicly available sources. Marlvel.ai is not affiliated with, endorsed by, or sponsored by ECG Buddy, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

What's new

The report shows a pivot toward clinical workflow integration and regulatory-driven market positioning, despite ongoing technical blockers in the onboarding funnel.

added

Expanded SWOT Analysis

removed

Feature List Consolidation

shifted

Strategic Trade-off Pivot

Cite this report

Marlvel.ai. “ECG Buddy Intelligence Report.” Updated Aug 13, 2026. https://marlvel.ai/apps/ecg-buddy

Agent Markdown (.md)See methodologyContact support

Data licensed under CC-BY-NC 4.0